Chuanling Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chuanling Zhang has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Demin Zhou
Peking University
5 shared publications Lihe Zhang
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China; Peking University Ningbo Institute of Marine Medicines, Ningbo, Zhejiang 315832, China
2 shared publicationsXiaoyang Wang
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China; Shenzhen Bay Laboratory, Gaoke International Innovation Center, Shenzhen, Guangdong 518107, China; Peking University Ningbo Institute of Marine Medicines, Ningbo, Zhejiang 315832, China; Peking University - Yunnan Baiyao International Medical Research Center, Beijing 100191, China
2 shared publicationsXinchen Wang
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China; Shenzhen Bay Laboratory, Gaoke International Innovation Center, Shenzhen, Guangdong 518107, China; Peking University Ningbo Institute of Marine Medicines, Ningbo, Zhejiang 315832, China; Peking University - Yunnan Baiyao International Medical Research Center, Beijing 100191, China
2 shared publicationsYu Mu
Shenzhen Bay Laboratory, Gaoke International Innovation Center, Shenzhen, Guangdong 518107, China; Peking University Ningbo Institute of Marine Medicines, Ningbo, Zhejiang 315832, China
2 shared publicationsYuanjie Zhang
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China; Shenzhen Bay Laboratory, Gaoke International Innovation Center, Shenzhen, Guangdong 518107, China; Peking University Ningbo Institute of Marine Medicines, Ningbo, Zhejiang 315832, China; Peking University - Yunnan Baiyao International Medical Research Center, Beijing 100191, China
2 shared publications
Latest Publications
- 13 February 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 380, 563-578
Engineering sialylated N-glycans on adeno-associated virus capsids for targeted gene delivery and therapeutic applications
- 13 February 2025
- Published by Elsevier in Journal of Controlled Release
- Vol. 380, 563-578
Engineering sialylated N-glycans on adeno-associated virus capsids for targeted gene delivery and therapeutic applications
- 16 July 2024
- Published by Elsevier in Acta Biomaterialia
- Vol. 187, 304-315
Site-specific tethering nanobodies on recombinant adeno-associated virus vectors for retargeted gene therapy
- 16 July 2024
- Published by Elsevier in Acta Biomaterialia
- Vol. 187, 304-315
Site-specific tethering nanobodies on recombinant adeno-associated virus vectors for retargeted gene therapy
- 6 February 2018
- Published by Wiley in Biotechnology Journal
- Vol. 13 (4) , e1700374
Precision Fluorescent Labeling of an Adeno‐Associated Virus Vector to Monitor the Viral Infection Pathway
Adeno‐associated virus 2 (AAV2) is a common vehicle for the delivery of a variety of therapeutic genes. A better understanding of the process of infection of AAV2 will advance our knowledge of AAV2 biology and allow for the optimization of AAV2 capsids with favorable transduction profiles. However, the precise fluorescent labeling of an AAV2 vector for probing virus tracking without affecting the nature of the virus remains a challenge. In this study, a lab‐synthesized azide‐moieties on the viral capsid at modifiable sites is precisely displayed. Upon bioorthogonal copper‐less click reaction, fluorophores are subsequently conjugated to AAV2 vectors for visualization of particles. Using this principle, the authors demonstrate that it can be used for visibly studying the cell entry, and intracellular trafficking of AAV2 particles, enabling the monitoring of the intracellular dynamics of AAV2 infection. This study provides new insights into the precision labeling of AAV2 particles with important implications for a better understanding of the molecular mechanism of therapeutic gene delivery.
- 6 February 2018
- Published by Wiley in Biotechnology Journal
- Vol. 13 (4) , e1700374
Precision Fluorescent Labeling of an Adeno‐Associated Virus Vector to Monitor the Viral Infection Pathway
Adeno‐associated virus 2 (AAV2) is a common vehicle for the delivery of a variety of therapeutic genes. A better understanding of the process of infection of AAV2 will advance our knowledge of AAV2 biology and allow for the optimization of AAV2 capsids with favorable transduction profiles. However, the precise fluorescent labeling of an AAV2 vector for probing virus tracking without affecting the nature of the virus remains a challenge. In this study, a lab‐synthesized azide‐moieties on the viral capsid at modifiable sites is precisely displayed. Upon bioorthogonal copper‐less click reaction, fluorophores are subsequently conjugated to AAV2 vectors for visualization of particles. Using this principle, the authors demonstrate that it can be used for visibly studying the cell entry, and intracellular trafficking of AAV2 particles, enabling the monitoring of the intracellular dynamics of AAV2 infection. This study provides new insights into the precision labeling of AAV2 particles with important implications for a better understanding of the molecular mechanism of therapeutic gene delivery.
- Open Access
Site-Specific PEGylated Adeno-Associated Viruses with Increased Serum Stability and Reduced Immunogenicity
Adeno-associated virus (AAV) is one of the most extensively studied and utilized viral vectors in clinical gene transfer research. However, the serum instability and immunogenicity of AAV vectors significantly limit their application. Here, we endeavored to overcome these limitations by developing a straightforward approach for site-specific PEGylation of AAV via genetic code expansion. This technique includes incorporation of the azide moiety into the AAV capsid protein followed by orthogonal and stoichiometric conjugation of a variety of polyethylene glycols (PEGs) through click chemistry. Using this approach, only the chosen site(s) was consistently PEGylated under mild conditions, preventing nonselective conjugation. Upon a series of in vitro examinations, AAVs conjugated with 20-kD PEG at sites Q325+1, S452+1, and R585+1 showed a 1.7- to 2.4-fold stability improvement in pooled human serum and a nearly twofold reduction in antibody recognition. Subsequent animal research on Sprague Dawley rats displayed a promising 20% reduction in antibody inducement and a higher virus titer in the blood. Together, our data demonstrate successful protection of an AAV vector from antibody neutralization and blood clearance, thereby increasing the efficiency of therapeutic gene delivery.
Open AccessSite-Specific PEGylated Adeno-Associated Viruses with Increased Serum Stability and Reduced Immunogenicity
Adeno-associated virus (AAV) is one of the most extensively studied and utilized viral vectors in clinical gene transfer research. However, the serum instability and immunogenicity of AAV vectors significantly limit their application. Here, we endeavored to overcome these limitations by developing a straightforward approach for site-specific PEGylation of AAV via genetic code expansion. This technique includes incorporation of the azide moiety into the AAV capsid protein followed by orthogonal and stoichiometric conjugation of a variety of polyethylene glycols (PEGs) through click chemistry. Using this approach, only the chosen site(s) was consistently PEGylated under mild conditions, preventing nonselective conjugation. Upon a series of in vitro examinations, AAVs conjugated with 20-kD PEG at sites Q325+1, S452+1, and R585+1 showed a 1.7- to 2.4-fold stability improvement in pooled human serum and a nearly twofold reduction in antibody recognition. Subsequent animal research on Sprague Dawley rats displayed a promising 20% reduction in antibody inducement and a higher virus titer in the blood. Together, our data demonstrate successful protection of an AAV vector from antibody neutralization and blood clearance, thereby increasing the efficiency of therapeutic gene delivery.
- Open Access
- 21 April 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , srep46569
Fatty acid synthase cooperates with protrudin to facilitate membrane outgrowth of cellular protrusions
Cellular protrusion formation capacity is a key feature of developing neurons and many eukaryotic cells. However, the mechanisms underlying membrane growth in protrusion formation are largely unclear. In this study, photo-reactive unnatural amino acid 3-(3-methyl-3H-diazirin-3-yl)-propamino-carbonyl-Nε-l-lysine was incorporated by a genetic code expansion strategy into protrudin, a protein localized in acidic endosomes and in the endoplasmic reticulum, that induces cellular protrusion and neurite formation. The modified protrudin was used for covalent trapping of protrudin-interacting proteins in living cells. Fatty acid synthase (FASN), which synthesizes free fatty acids, was identified to transiently interact with protrudin. Further characterization revealed a unique cooperation mechanism in which protrudin cooperates with FASN to facilitate cellular protrusion formation. This work reveals a novel mechanism involved in protrusion formation that is dependent on transient interaction between FASN and protrudin, and establishes a creative strategy to investigate transient protein-protein interactions in mammalian cells.
- 21 April 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , srep46569
Open AccessFatty acid synthase cooperates with protrudin to facilitate membrane outgrowth of cellular protrusions
Cellular protrusion formation capacity is a key feature of developing neurons and many eukaryotic cells. However, the mechanisms underlying membrane growth in protrusion formation are largely unclear. In this study, photo-reactive unnatural amino acid 3-(3-methyl-3H-diazirin-3-yl)-propamino-carbonyl-Nε-l-lysine was incorporated by a genetic code expansion strategy into protrudin, a protein localized in acidic endosomes and in the endoplasmic reticulum, that induces cellular protrusion and neurite formation. The modified protrudin was used for covalent trapping of protrudin-interacting proteins in living cells. Fatty acid synthase (FASN), which synthesizes free fatty acids, was identified to transiently interact with protrudin. Further characterization revealed a unique cooperation mechanism in which protrudin cooperates with FASN to facilitate cellular protrusion formation. This work reveals a novel mechanism involved in protrusion formation that is dependent on transient interaction between FASN and protrudin, and establishes a creative strategy to investigate transient protein-protein interactions in mammalian cells.